TY  - GEN
AU  - Kopetz,Scott
AU  - Grothey,Axel
AU  - Yaeger,Rona
AU  - Van Cutsem,Eric
AU  - Desai,Jayesh
AU  - Yoshino,Takayuki
AU  - Wasan,Harpreet
AU  - Ciardiello,Fortunato
AU  - Loupakis,Fotios
AU  - Hong,Yong Sang
AU  - Steeghs,Neeltje
AU  - Guren,Tormod K
AU  - Arkenau,Hendrik-Tobias
AU  - Garcia-Alfonso,Pilar
AU  - Pfeiffer,Per
AU  - Orlov,Sergey
AU  - Lonardi,Sara
AU  - Elez,Elena
AU  - Kim,Tae-Won
AU  - Schellens,Jan H M
AU  - Guo,Christina
AU  - Krishnan,Asha
AU  - Dekervel,Jeroen
AU  - Morris,Van
AU  - Calvo Ferrandiz,Aitana
AU  - Tarpgaard,L S
AU  - Braun,Michael
AU  - Gollerkeri,Ashwin
AU  - Keir,Christopher
AU  - Maharry,Kati
AU  - Pickard,Michael
AU  - Christy-Bittel,Janna
AU  - Anderson,Lisa
AU  - Sandor,Victor
AU  - Tabernero,Josep
TI  - Encorafenib, Binimetinib, and Cetuximab in 
SN  - 1533-4406
PY  - 2019///1106
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Benzimidazoles
KW  - administration & dosage
KW  - Carbamates
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease Progression
KW  - Electrocorticography
KW  - Female
KW  - Humans
KW  - Intention to Treat Analysis
KW  - Irinotecan
KW  - therapeutic use
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Proto-Oncogene Proteins B-raf
KW  - genetics
KW  - Sulfonamides
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1908075
ER  -